Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in BCYC — Bicycle Therapeutics PLC

CIK 1263508 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$46,153,913
-$4,354,143 QoQ
Shares Held
10,885,357
0.0% QoQ
Ownership
15.6%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1
of 103 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. BCYC ranks #34 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in BCYC

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,153,913 10,885,357
2026-03-31 $50,508,056 10,885,357
2025-12-31 $77,068,327 10,885,357
2025-09-30 $84,252,663 10,885,357
2025-06-30 $75,653,231 10,885,357
2025-03-31 $92,416,680 10,885,357
2024-12-31 $152,394,998 10,885,357
2024-09-30 $212,721,094 9,399,960
2024-06-30 $190,255,190 9,399,960
2024-03-31 $123,076,292 4,942,823
2023-12-31 $32,370,251 1,790,390
2023-09-30 $16,952,223 843,814
2023-06-30 $21,534,133 843,814
2023-03-31 $17,947,923 843,814
2022-12-31 $24,976,894 843,814
2022-09-30 $19,627,113 843,814